Downregulation of Cystine Transporter Xc– By Irinotecan in Human Head and Neck Cancer FaDu Xenografts

Chemotherapy - Switzerland
doi 10.1159/000316334
Full Text
Abstract

Available in full text

Date
Authors
Publisher

S. Karger AG

Related search

Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

114 Fluoropyrimidine Metabolism in Human Head and Neck Cancer Xenografts and Murine Colon Tumors

Pediatric Research
Child HealthPediatricsPerinatology
1988English

Chemosensitivity of Human Head and Neck Cancer Xenografts in the Clonogenic Assay and in Nude Mice

British Journal of Cancer
Cancer ResearchOncology
1986English

Extracellular Thiol-Assisted Selenium Uptake Dependent on the Xc- Cystine Transporter Explains the Cancer-Specific Cytotoxicity of Selenite

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Sensitivity and Specificity of Fluorescent Immunoguided Neoplasm Detection in Head and Neck Cancer Xenografts

Archives of Otolaryngology–Head & Neck Surgery
2007English

Establishment and Characterization of Patient-Derived Xenografts as Paraclinical Models for Head and Neck Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Targeting Head and Neck Cancer by Vaccination

Frontiers in Immunology
AllergyImmunology
2018English

Human Papilloma Virus in Head and Neck Squamous Cell Cancer.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Head and Neck Cancer

Journal of Oncology
Oncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy